Investegate |RUA Life Sciences Announcements | RUA Life Sciences: Half-year Report
Unaudited Interim Results RUA Life Sciences plc (AIM: RUA), the holding company of a group of medical device businesses focused on the exploitation of Elast-Eon™, a long-term implantable biostable polymer , announces its unaudited interim results for the six months ended 30 September 2020. Highlights · Products on schedule for regulatory submission in 2021 · Positive testing on polymeric heart valve · The Group's cash continues to be well managed with cash at 30 September 2020 of £1,009,000 (31 ...